Eton Pharmaceuticals, Inc. (ETON) (CIK 0001710340) (ETON)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jan. 27, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Eton Pharmaceuticals, Inc.'s recent filings, including the Form 10-K for the fiscal year ended December 31, 2024 and the Form 8-K filed on Nove… | Read Filing EDGAR |
| Jan. 14, 2026 | CORRESP | Concern from SEC | Moderate | Eton Pharmaceuticals, Inc. submitted a response to the SEC regarding comments on their Form 10-K and Form 8-K filings. The SEC raised questions about the accounting treatment of a… | Read Filing EDGAR |
| Dec. 19, 2025 | UPLOAD | Concern from SEC | High | The SEC has issued comments regarding Eton Pharmaceuticals' recent filings, specifically focusing on the financial statements and disclosures related to a business combination and… | Read Filing EDGAR |